Emmanuel Mitry

9.8k total citations · 1 hit paper
127 papers, 6.8k citations indexed

About

Emmanuel Mitry is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emmanuel Mitry has authored 127 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 40 papers in Epidemiology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emmanuel Mitry's work include Colorectal Cancer Treatments and Studies (39 papers), Neuroendocrine Tumor Research Advances (33 papers) and Pancreatic and Hepatic Oncology Research (25 papers). Emmanuel Mitry is often cited by papers focused on Colorectal Cancer Treatments and Studies (39 papers), Neuroendocrine Tumor Research Advances (33 papers) and Pancreatic and Hepatic Oncology Research (25 papers). Emmanuel Mitry collaborates with scholars based in France, United Kingdom and Belgium. Emmanuel Mitry's co-authors include Philippe Rougier, P. Rougier, Solange Peters, M. Pérol, Bogdana Balas, Jin Seok Ahn, Tony Mok, Rafael Rosell, Shirish M. Gadgeel and Ali Zeaiter and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Emmanuel Mitry

123 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

2017 1.6k citations Solange Peters, D. Ross Camidge et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emmanuel Mitry France	39	5.2k	2.9k	1.5k	1.2k	1.1k	127	6.8k
Lawrence S. Blaszkowsky United States	37	3.5k 0.7×	1.8k 0.6×	1.2k 0.8×	1.6k 1.3×	1.0k 0.9×	182	5.5k
David Malka France	57	5.5k 1.1×	2.6k 0.9×	1.4k 0.9×	4.1k 3.4×	1.7k 1.5×	233	9.3k
Javier Sastre Spain	39	4.8k 0.9×	1.9k 0.7×	751 0.5×	1.2k 1.0×	1.5k 1.3×	177	6.7k
Côme Lepage France	39	3.5k 0.7×	1.5k 0.5×	943 0.6×	1.8k 1.5×	988 0.9×	214	5.3k
Laëtitia Dahan France	36	3.5k 0.7×	1.7k 0.6×	1.9k 1.3×	1.5k 1.2×	394 0.4×	144	5.3k
Peter C. Enzinger United States	39	4.2k 0.8×	3.5k 1.2×	1.5k 1.0×	3.4k 2.8×	510 0.5×	147	8.4k
George A. Poultsides United States	54	5.7k 1.1×	4.3k 1.5×	1.9k 1.3×	4.8k 4.0×	1.2k 1.1×	397	10.1k
Richard Hubner United Kingdom	33	3.4k 0.7×	1.2k 0.4×	1.1k 0.8×	1.6k 1.3×	691 0.6×	199	5.5k
Gabriele Luppi Italy	28	3.4k 0.7×	1.3k 0.5×	794 0.5×	1.7k 1.4×	360 0.3×	105	4.3k
Axel Hinke Germany	40	5.6k 1.1×	3.1k 1.1×	906 0.6×	2.0k 1.7×	302 0.3×	189	8.5k

Countries citing papers authored by Emmanuel Mitry

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Mitry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Mitry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Mitry more than expected).

Fields of papers citing papers by Emmanuel Mitry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Mitry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Mitry. The network helps show where Emmanuel Mitry may publish in the future.

Co-authorship network of co-authors of Emmanuel Mitry

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Mitry. A scholar is included among the top collaborators of Emmanuel Mitry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Mitry. Emmanuel Mitry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laethem, Jean–Luc Van, Ivan Borbath, Hans Prenen, et al.. (2024). Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study. The Lancet Oncology. 25(7). 853–864. 23 indexed citations

Peters, Solange, D. Ross Camidge, Alice T. Shaw, et al.. (2017). Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer. New England Journal of Medicine. 377(9). 829–838. 1619 indexed citations breakdown →

Charachon, Antoine, Christophe Locher, Thomas Aparicio, et al.. (2015). Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter study. Clinics and Research in Hepatology and Gastroenterology. 40(2). 230–238. 17 indexed citations

Baudin, Éric, Philippe Caron, Catherine Lombard‐Bohas, et al.. (2013). Malignant insulinoma: Recommendations for characterisation and treatment. Annales d Endocrinologie. 74(5-6). 523–533. 50 indexed citations

Mestier, Louis de, Clarisse Dromain, Gaspard d’Assignies, et al.. (2013). Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art. Endocrine Related Cancer. 21(3). R105–R120. 59 indexed citations

Trésallet, Christophe, Antoine Brouquet, Catherine Julié, et al.. (2011). Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome. International Journal of Cancer. 130(6). 1367–1377. 18 indexed citations

Roux, Catherine Le, Catherine Lombard‐Bohas, Christelle Delmas, et al.. (2011). Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study. Digestive and Liver Disease. 43(10). 828–833. 43 indexed citations

Mitry, Emmanuel, Pascal Hammel, G. Deplanque, et al.. (2010). Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 66(2). 395–403. 52 indexed citations

Lièvre, Astrid, Étienne Rouleau, Bruno Buecher, & Emmanuel Mitry. (2010). [Clinical significance of BRAF mutations in colorectal cancer].. PubMed. 97(12). 1441–52. 8 indexed citations

10.

Papamichael, D., Riccardo A. Audisio, Bengt Glimelius, et al.. (2008). Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Annals of Oncology. 20(1). 5–16. 134 indexed citations

11.

Mitry, Emmanuel, Bernard Rachet, M J Quinn, Nicola Cooper, & Michel P. Coleman. (2008). Survival from cancer of the rectum in England and Wales up to 2001. British Journal of Cancer. 99(S1). S30–S32. 22 indexed citations

12.

Rachet, Bernard, Emmanuel Mitry, Anjali Shah, Nicola Cooper, & Michel P. Coleman. (2008). Survival from non-Hodgkin lymphoma in England and Wales up to 2001. British Journal of Cancer. 99(S1). S104–S106. 11 indexed citations

13.

Julié, Catherine, Christophe Trésallet, Antoine Brouquet, et al.. (2008). Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based ApproachVersusMolecular Screening. The American Journal of Gastroenterology. 103(11). 2825–2835. 89 indexed citations

14.

Mitry, Emmanuel, Bernard Rachet, M J Quinn, Nicola Cooper, & Michel P. Coleman. (2008). Survival from cancer of the colon in England and Wales up to 2001. British Journal of Cancer. 99(S1). S26–S29. 19 indexed citations

15.

Nur, Ula, Bernard Rachet, Emmanuel Mitry, Nicola Cooper, & Michel P. Coleman. (2008). Survival from testicular cancer in England and Wales up to 2001. British Journal of Cancer. 99(S1). S80–S82. 20 indexed citations

16.

Mitry, Emmanuel, Nicolas Mansencal, Céline Lepère, et al.. (2007). Risk of venous thrombosis in patients with pancreatic adenocarcinoma. Gastroentérologie Clinique et Biologique. 31(12). 1139–1142. 19 indexed citations

17.

Marrache, Frédéric, Marie‐Pierre Vullierme, Carine Roy, et al.. (2006). Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. British Journal of Cancer. 96(1). 49–55. 68 indexed citations

18.

Mitry, Emmanuel, Julien Taı̈eb, Pascal Artru, et al.. (2004). Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastricor gastroesophageal junction carcinoma. Annals of Oncology. 15(5). 765–769. 28 indexed citations

19.

Taı̈eb, Julien, Emmanuel Mitry, Valérie Boige, et al.. (2002). Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Annals of Oncology. 13(8). 1192–1196. 78 indexed citations

20.

Mitry, Emmanuel, et al.. (2002). Surgery for colon and rectal cancer. Best Practice & Research Clinical Gastroenterology. 16(2). 253–265. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact